Contact Us   |  Client Login  
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home > Investors > Financial Information > Press Releases
Financial Information
Press Releases
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013

DateTitle
15-Dec-2009Covance Opens New Clinical Development Offices in South Korea and India; Expands Offices in Japan and Hong Kong Print
01-Dec-2009Covance to Establish a New Nutritional Chemistry and Food Safety Laboratory in Battle Creek, Michigan Print
18-Nov-2009Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. Print
26-Oct-2009Covance Receives AAALAC Accreditation for Early Development Facility in Chandler Print
21-Oct-2009Covance Reports Third Quarter Revenue of $475M and EPS of $0.67 Per Share Print
28-Sep-2009Covance Announces New cGMP Melamine Testing Service Print
11-Sep-2009Covance Receives ISO Accreditation for North America Nutritional Chemistry and Food Safety Laboratory Print
09-Sep-2009Covance Opens New Clinical Development Offices in Brazil and Mexico Print
18-Aug-2009Covance and Merck & Co., Inc. Finalize Strategic Agreement Print
31-Jul-2009Covance Becomes First CRO to Globally Deliver Innovative Technique for TK/PK Sampling Print
30-Jul-2009Covance Receives Highest Level of Phase I Accreditation Print
29-Jul-2009Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 Print
29-Jul-2009Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc. Print
27-Jul-2009Covance Doubles Service Capacity, Expertise for Metabolite Identification Print
15-Jul-2009Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward Print
07-Jul-2009Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services Print
29-Jun-2009Covance Expands Analytical and Stability Service Capacity in North America Print
23-Jun-2009Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies Print
27-May-2009Covance Recognized for Outstanding Customer Service by Eli Lilly and Company Print
07-May-2009Covance Elects John McCartney to Company's Board of Directors Print
29-Apr-2009Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets Print
07-Apr-2009Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office Print
06-Apr-2009Covance Central Laboratory Receives CAP Accreditation in China Print
31-Mar-2009Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum Print
13-Mar-2009Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site Print
19-Feb-2009Covance Elects Bradley T. Sheares to Company's Board of Directors Print
18-Feb-2009Covance Increases Biotechnology Service Capacity in Europe, Receives cGMP Manufacturing License Print
03-Feb-2009Covance Opens Three New Offices in Ukraine, Slovakia, and Israel Print
28-Jan-2009Covance Reports Fourth Quarter and Full-Year 2008 Results Print


Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2013 Covance Inc. All rights reserved.